![]()
A) A muscle abnormality. B) A skin condition. C) A type of blood cell. D) An abnormal growth of tissue in bone.
A) Only from the bone itself. B) From the liver. C) From the brain. D) From cancers in another part of the body such as lung, breast, thyroid, kidney, and prostate.
A) A pathologic fracture. B) A broken rib. C) A dislocated shoulder. D) A sprained ankle.
A) Coughing and sneezing. B) Blurred vision. C) Hearing loss. D) Fatigue, fever, weight loss, anemia, and nausea.
A) By X-ray and other radiological tests such as CT scan, MRI, PET scan, and bone scintigraphy. B) By urine color analysis. C) By a physical exam alone. D) By blood pressure measurement.
A) Cholesterol levels. B) Complete blood count, inflammatory markers, serum electrophoresis, PSA, kidney function, and liver function. C) Hemoglobin A1c. D) Blood sugar levels.
A) Glucose. B) Protein levels. C) Bence Jones protein. D) Urea.
A) A dietary consultation. B) A biopsy for histological evaluation. C) A blood transfusion. D) A physical therapy session.
A) Non-ossifying fibroma. B) Ewing sarcoma. C) Chondrosarcoma. D) Osteosarcoma.
A) 50%. B) 85%. C) 68%. D) 90%.
A) In a hand bone in Egypt. B) In a rib bone in India. C) In a foot bone in South Africa. D) In a skull bone in China.
A) Tumors that originate in the liver. B) Tumors that originate in the brain. C) Tumors that originate in the lungs. D) Tumors that originate in bone or from bone-derived cells and tissues.
A) Tumors that originate in the heart. B) Tumors that originate in other sites and spread to the skeleton. C) Tumors that originate in the kidneys. D) Tumors that originate in the skin.
A) Lungs, liver, and pancreas. B) Prostate, breasts, lungs, thyroid, and kidneys. C) Skin, brain, and ovaries. D) Stomach, colon, and bladder.
A) Chondrosarcoma. B) Osteosarcoma. C) Osteochondroma. D) Ewing sarcoma.
A) Metastatic tumor. B) Bone sarcoma. C) Benign tumor. D) Hamartoma.
A) Chest and abdomen. B) Spine and pelvis. C) Distal femur and proximal tibia. D) Shoulder and elbow.
A) Leukemia. B) Multiple myeloma. C) Thrombocytopenia. D) Lymphoma.
A) In the midline of the sacrum, coccyx, or both. B) In the lungs. C) In the kidneys. D) In the liver.
A) Using only physical exams. B) Using only X-rays. C) Using specialized studies like genetic and immunohistochemical tests. D) Using only blood tests.
A) Fibrosarcoma B) Chondrosarcoma C) Ewing sarcoma D) Osteosarcoma
A) Neurological signs B) Increased muscle tone C) Improved reflexes D) Enhanced coordination
A) They do not require diagnosis B) They are always benign C) They are easily treated with medication D) They are rarely ever curable
A) Intravenous chemotherapy B) Oral chemotherapy C) Intra-arterial protocol with serial arteriogram D) Topical chemotherapy
A) When tumor response has reached >90% necrosis B) After 6 months of treatment C) When tumor response is <50% necrosis D) Immediately after chemotherapy starts
A) Strontium-89 chloride B) Non-hormonal bisphosphonates C) Chemotherapy drugs D) Radiotherapy
A) Radiotherapy B) Chemotherapy C) Joint preservation surgical reconstruction D) Limb amputation
A) Chemotherapy B) External beam radiation therapy C) Surgical resection D) Pain medication
A) The outcome is generally good. B) The outcome is always fatal. C) The outcome is poor. D) The outcome is uncertain.
A) No, they remain benign forever. B) Yes, some types may eventually become malignant. C) No, they never become cancerous. D) Yes, all benign tumors become cancerous.
A) All patients are cured. B) Cure rate is independent of tumor type, location, and size. C) Cure is impossible. D) Most patients achieve a cure, but it depends on various factors.
A) Around 0.2%. B) Around 50%. C) Around 5%. D) Around 10%. |